Intrathecal morphine 100 and 200 μg for post-cesarean delivery analgesia: a trade-off between analgesic efficacy and side effects.
J Y Wong, B Carvalho, E T Riley
https://pubmed.ncbi.nlm.nih.gov/23159009/Actively Recruiting
Led by University of Liege · Updated on 2025-04-15
400
Participants Needed
2
Research Sites
4 weeks
Total Duration
Researchers are studying the frequency and risk factors of nausea and vomiting after planned caesarean sections performed under spinal anesthesia. This observational study focuses on patients receiving intrathecal morphine and multimodal antiemetic preventive treatment to understand how often these symptoms occur and what might increase the risk. It aims to provide detailed insights into postoperative nausea and vomiting during elective caesarean delivery. Participants will undergo their caesarean section following the standard care protocol, including spinal anesthesia with intrathecal morphine and preventive anti-nausea medications. There are no experimental treatments or interventions beyond this usual care. The study will observe and record nausea and vomiting from the time of surgery through the first 24 hours post-operation. Patients will be asked specific questions about nausea and vomiting shortly after surgery in the recovery room and during two additional visits within the first 24 hours following their caesarean. The main outcome measured is the occurrence of nausea and vomiting during this period, while secondary outcomes focus on identifying risk factors. This study is sponsored by the University of Liege and will continue until April 2026.
CONDITIONS
Frequency of Occurrence and Risk Factors of Postoperative Nausea and Vomiting During Elective C-section Under Spinal Anesthesia With Preventive Medication
T
Thibault Michot, M.D.
F
Fernande J Lois, M.D., PhD
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
University of Liege
Lead Sponsor
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - From cesarean section to the 24th postoperative hour
Participants who undergo elective cesarean section under spinal anesthesia are observed for nausea and vomiting during and after surgery.
1 perioperative visit and observation until 24 hours post-surgery
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Have more questions? Get in touch with our team for quick support
J Y Wong, B Carvalho, E T Riley
https://pubmed.ncbi.nlm.nih.gov/23159009/Laurent Bollag, Grace Lim, Pervez Sultan...
https://pubmed.ncbi.nlm.nih.gov/33177330/M Van De Velde, M Vercauteren, W Stockman...
https://pubmed.ncbi.nlm.nih.gov/24279198/Aaron B Caughey, Stephen L Wood, George A Macones...
https://pubmed.ncbi.nlm.nih.gov/30118692/C C Apfel, E Läärä, M Koivuranta...
https://pubmed.ncbi.nlm.nih.gov/10485781/H S Tan, M Cooter, R B George...
https://pubmed.ncbi.nlm.nih.gov/32950029/L Sentilhes, T Schmitz, H Madar...
https://pubmed.ncbi.nlm.nih.gov/36228999/E Roofthooft, G P Joshi, N Rawal...
https://pubmed.ncbi.nlm.nih.gov/33370462/M Balki, J C A Carvalho
https://pubmed.ncbi.nlm.nih.gov/15935649/University of Liege
Lead Sponsor